Fig. 6From: In silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approachSide view of the compound 1c on the OSIRIS Property Explorer interface showing physicochemical characteristics including Toxicity RisksBack to article page